Journal list menu
Alzheimer's & Dementia
Editor-in-Chief: Zaven S. Khachaturian, PhD
Executive Editor: Ara S. Khachaturian, PhD
About the Journal
Alzheimer’s & Dementia® aims to bridge the knowledge gaps across a wide range of bench-to-bedside investigation in dementia and Alzheimer's Disease.
The Alzheimer’s Association celebrates the career, character and contributions of John Trojanowski, M.D., Ph.D. Read the full tribute >>
Article featured in the November issue of Alzheimer’s & Dementia:
Article featured in the December issue of Alzheimer’s & Dementia:
- Knowledge gaps in Alzheimer's disease immune biomarker research
- The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology
- Association of Life's Simple 7 with incident dementia and its modification by the apolipoprotein E genotype
- Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020–2060)
Article featured in the Janurary issue of Alzheimer’s & Dementia:
- Developing a pathway to support the appropriate, affordable, and widespread use of effective Alzheimer's prevention drugs
- Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe
- Beta-amyloid pore linked to controlled calcium influx into the cell: A new paradigm for Alzheimer's Disease
- Projecting the long-term societal value of a disease-modifying treatment for Alzheimer's disease in the United States
- Hypothesis: JNK signaling is a therapeutic target of neurodegenerative diseases
Articles
Examining the association between blood‐based biomarkers and human post mortem neuropathology in the University of Kentucky Alzheimer's Disease Research Center autopsy cohort
- 10 March 2022
Prevalence of dementia and mild cognitive impairment in indigenous Bolivian forager‐horticulturalists
- 9 March 2022
The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- 263-269
- 22 April 2011
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
- 535-562
- 1 April 2018
Alzheimer's‐like signaling in brains of COVID‐19 patients
- Alzheimer's & Dementia
- 3 February 2022
Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019
- Alzheimer's & Dementia
- 696-701
- 1 November 2020
The chronic neuropsychiatric sequelae of COVID‐19: The need for a prospective study of viral impact on brain functioning
- Alzheimer's & Dementia
- 1056-1065
- 5 January 2021
Altmetric measures the online attention that an article receives. Click here to view the latest trending articles from Alzheimer’s & Dementia based on attention in the past week.
The list below shows the top 3 Alzheimer’s & Dementia articles based on all-time Altmetric scores:
Recent issues
Latest news
Stay Connected with the Alzheimer’s Association®
The Alzheimer’s Association® advances research to end Alzheimer’s and dementia while enhancing care for those living with the diseases. The Alzheimer’s Association is the largest non-profit funder of Alzheimer’s disease research. Its mission is “to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health”.
- ISTAART
- AAIC Conference
- International Grant Program
- TrialMatch
- Research Program
- About the Association
Follow the Alzheimer’s Association®:
Published on behalf of the
Search articles from all three publications, and keep up with the latest information on the Alzheimer's Association® journal hub page.
Go to the society hub >>
Companion Journals
Read the 2021 Alzheimer's disease facts and figures HERE
View the infographic HERE
ALZHEIMER'S DRUG DEVELOPMENT & FUNDING
Read the 2021 Alzheimer's Disease Drug Development Pipeline HEREView the infographic HERE
Calls for Papers
Stay Connected with the Alzheimer's Association ®
The Alzheimer’s Association® advances research to end Alzheimer’s and dementia while enhancing care for those living with the diseases. The Alzheimer’s Association is the largest non-profit funder of Alzheimer’s disease research. Its mission is “to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health”.
- ISTAART
- AAIC Conference
- International Grant Program
- TrialMatch
- Research Program
- About the Association
Follow the Alzheimer’s Association®:
